Ar­ix IPO rais­es £100M for new biotech in­vest­ments; San­thera sets up shop in Mass­a­chu­setts

• As ex­pect­ed, the UK’s Ar­ix Bio­sciences has raised £100 mil­lion in its IPO, which will now fu­el a new round of in­vest­ments in biotech com­pa­nies. “We have a high­ly ex­pe­ri­enced in­ter­na­tion­al team and this new cap­i­tal en­ables us to con­tin­ue our com­mit­ment to sup­port­ing busi­ness­es in the van­guard of med­ical in­no­va­tion, with the ul­ti­mate goal of im­prov­ing out­comes for pa­tients and un­lock­ing val­ue for in­vestors,” said CEO Joe An­der­son.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.